A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relapsed or Refractory Aggressive B-cell Lymphomas
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
